Shortages of crucial cancer medications continue to impact US healthcare
Today, the National Comprehensive Cancer Network® (NCCN®)-an alliance of leading cancer centers-published updated data on the current impact…
Targeting metabolic pathways could prevent relapse in KRAS-mutant cancers
Our cells rely on tightly regulated signaling pathways to control when they grow, divide, and survive. When these…
ESMO and EURACAN call for policy action to standardize care for patients with rare cancers
Adherence to Clinical Practice Guidelines in the management of rare cancers remains inconsistent across Europe despite demonstrably improving…
How somatic mutations shape disease and reveal new drug targets
Scientists reveal how evolution within our own tissues can drive disease, protect cells, and uncover hidden therapeutic targets…
Study shows one in ten young cancer patients develop metastatic recurrence
A new study of adolescents and young adults (AYAs) with seven common cancers reveals that nearly one in…
Highly targeted gene therapy could revolutionize treatment for cancers linked to herpesvirus
In a preclinical study, UC Davis Comprehensive Cancer Center scientists developed a highly targeted gene therapy that could…